Evaluation of Pharmacodynamic Effects on Ovulation Suppression and Cycle Control of Three Agile Contraceptive Patches Containing Different Doses of Ethinyl Estradiol(EE)During Three Cycles of Administration.

Trial Profile

Evaluation of Pharmacodynamic Effects on Ovulation Suppression and Cycle Control of Three Agile Contraceptive Patches Containing Different Doses of Ethinyl Estradiol(EE)During Three Cycles of Administration.

Completed
Phase of Trial: Phase II

Latest Information Update: 02 May 2011

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 02 May 2011 Results have been published in Hormone Molecular Biology and Clinical Investigation, according to a Agile Therapeutics media release.
    • 29 Nov 2010 Official title, actual initiation date (Sep 2007), actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 29 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top